In 2025, the South African market was assessed at USD 1.15 billion.
By the end of 2033, the South Africa Infusion Services Market size is expected to reach USD 2.45 billion, reflecting a CAGR of 9.8% throughout the forecast window.
Private hospital groups remain the primary drivers of biologic infusion services, particularly within oncology-focused tertiary facilities.
South Africa National Cancer Registry data confirm persistent cancer burden, sustaining systemic therapy demand across both public and private sectors.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]